Expression of concern
Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway
Paper Information
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.3389/fcell.2022.1014332Citations (27)
27
Total Citations21
Post-Retraction(77.8%)
6
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
10
Within 1 year
4
After 2+ years
826
Days since retraction (latest)
Male Wistar Rats Chronically Fed with a High-Fat Diet Develop Inflammatory and Ionic Transport Angiotensin-(3–4)-Sensitive Myocardial Lesions but Preserve Echocardiographic Parameters
Thuany Crisóstomo, Rafael Luzes, Matheus Leonardo Lima Gonçalves et al. (8 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2024
826 days after retraction
Study on Cardiac Transcriptomic Changes and Inflammatory Responses Induced by Acute Kidney Injury in a Cardiorenal Syndrome Model
Xiaolu DING, Yuchen HE, Xiaodan Liu et al. (4 authors)
Research Square (Research Square)
Published: Oct 2024
776 days after retraction
The Role of Oxidative Stress as a Mechanism in the Pathogenesis of Acute Heart Failure in Acute Kidney Injury
Danijela Tasić, Zorica Dimitrijević
Diagnostics
Open Access
Published: Sep 2024
1 citation
1 citation
768 days after retraction
Role of Mitochondria in Reno-Cardiac Diseases: A Study of Bioenergetics, Biogenesis, and GSH Signaling in Disease Transition
Jairo Lumpuy‐Castillo, Isabel Amador‐Martínez, Miriam Díaz-Rojas et al. (7 authors)
Redox Biology
Open Access
Published: Sep 2024
9 citations
9 citations
751 days after retraction
The Role Of Oxidative Stress As A Mechanism In The Pathogenesis Of Heart Failure In Acute Kidney Injury
Danijela Tasić
Unknown Journal
Open Access
Published: May 2024
1 citation
1 citation
644 days after retraction
Proteomic Analysis of Prehypertensive and Hypertensive Patients: Exploring the Role of the Actin Cytoskeleton
Sarah Al Ashmar, Gulsen Guliz Anlar, Hubert Krzyslak et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2024
2 citations
2 citations
622 days after retraction
Hippo pathway activated by circulating reactive oxygen species mediates cardiac diastolic dysfunction after acute kidney injury
Xiao Han, Quan Hong, Fei Peng et al. (8 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Published: Apr 2024
3 citations
3 citations
613 days after retraction
Protein–protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis
Evridiki-Pandora Tsare, Maria I. Klapa, Nicholas Κ. Moschonas
Human Genomics
Open Access
Published: Feb 2024
5 citations
5 citations
540 days after retraction
Dual-specificity phosphatase 1 interacts with prohibitin 2 to improve mitochondrial quality control against type-3 cardiorenal syndrome
Nanyang Liu, Yanqiu Ding, Hao Zhou et al. (5 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2024
6 citations
6 citations
502 days after retraction
Phytochemicals from Piper betle (L.) as Putative Modulators of a Novel Network-Derived Drug Target for Coronary Artery Disease: An In Silico Study
Sudhan, V. Janakiraman, Sheikh F. Ahmad et al. (5 authors)
Processes
Open Access
Published: Oct 2023
5 citations
5 citations
434 days after retraction
Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia
Yun Wang, Huang Qinqin, Haixia Wang et al. (8 authors)
Medicine
Open Access
Published: Sep 2023
3 citations
3 citations
394 days after retraction
NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3
Belén Cuevas-López, Edgar Ignacio Romero-Ramirez, Fernando E. García‐Arroyo et al. (15 authors)
Antioxidants
Open Access
Published: Aug 2023
10 citations
10 citations
358 days after retraction
Dapagliflozin protects heart function against type-4 cardiorenal syndrome through activation of PKM2/PP1/FUNDC1-dependent mitophagy
Yang Shen, Xiaojie Peng, Haizhe Ji et al. (6 authors)
International Journal of Biological Macromolecules
Published: Aug 2023
11 citations
11 citations
350 days after retraction
Impaired microvascular circulation in distant organs following renal ischemia
Jesus H. Dominguez, Danhui Xie, Katherine J. Kelly
PLoS ONE
Open Access
Published: Jun 2023
4 citations
4 citations
289 days after retraction
Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis
Mengjie Huang, Yuwei Ji, Jianwen Chen et al. (16 authors)
Acta Pharmacologica Sinica
Open Access
Published: Apr 2023
15 citations
15 citations
239 days after retraction
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Yong Liu, Xu Guan, Yuming Shao et al. (5 authors)
Reviews in Cardiovascular Medicine
Open Access
Published: Feb 2023
2 citations
2 citations
173 days after retraction
Urinary insulin signaling pathway related proteins may serve as potential biomarkers for monitoring diabetes mellitus without hypertension and hyperlipidemia
Man Zhao, Qian Meng, Man Zhang
Medicine
Open Access
Published: Feb 2023
3 citations
3 citations
170 days after retraction
Cardiac effects of renal ischemia
Jesus H. Dominguez, Danhui Xie, Katherine J. Kelly
AJP Renal Physiology
Published: Nov 2022
10 citations
10 citations
92 days after retraction
Autologous Extracellular Vesicles Attenuate Cardiac Injury in Experimental Atherosclerotic Renovascular Disease More Effectively Than Their Parent Mesenchymal Stem/Stromal Cells
Siting Hong, Xiangyang Zhu, Yamei Jiang et al. (11 authors)
Stem Cell Reviews and Reports
Published: Nov 2022
2 citations
2 citations
82 days after retraction
Cardiorenal Syndrome Type 3 Review
Robin Okpara, Camilo Peña, Kenneth Nugent
Cardiology in Review
Published: Oct 2022
6 citations
6 citations
54 days after retraction
Dapagliflozin attenuates residual cardiac remodeling after surgical ventricular reconstruction in mice with an enlarged heart after myocardial infarction
Siyuan Ma, Lu Chen, Junyu Yan et al. (15 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2022
6 citations
6 citations
54 days after retraction
Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome
Chen Cai, Feng Wu, Bingjie Zhuang et al. (11 authors)
Molecular Metabolism
Open Access
Published: Jul 2022
22 citations
22 citations
29 days before retraction
Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation
Jimin Dai, Xueqin Zhang, Jia‐Jia Zhang et al. (7 authors)
MedComm
Open Access
Published: May 2022
6 citations
6 citations
103 days before retraction
Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
Shuqing Shi, Bingxuan Zhang, Yumeng Li et al. (13 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Feb 2022
17 citations
17 citations
173 days before retraction
Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?
Daniel Patschan, Benedikt Marahrens, Monique Jänsch et al. (5 authors)
Journal of Clinical Medicine Research
Open Access
Published: Jan 2022
11 citations
11 citations
228 days before retraction
BI-1 ameliorates myocardial injury by activating the mitochondrial unfolded protein response and FUNDC1-related mitophagy in cardiorenal syndrome type 3
Jin Wang, Xiaohua Wang, Wenjuan Du et al. (7 authors)
Cellular Signalling
Published: Dec 2021
22 citations
22 citations
245 days before retraction
Mitochondrial Bioenergetic and Proteomic Phenotyping Reveals Organ-Specific Consequences of Chronic Kidney Disease in Mice
Trace Thome, Madeline Coleman, Terence E. Ryan
Cells
Open Access
Published: Nov 2021
18 citations
18 citations
266 days before retraction
Quick Stats
Total Citations:
27
Years Since Retraction:
3.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025